av/aikido-pharma--big.svg

NASDAQ:AIKI

AIkido Pharma Inc.

  • Stock

USD

Last Close

3.53

22/12 05:00

Market Cap

19.53M

Beta: -

Volume Today

31.93K

Avg: 35.26K

PE Ratio

−0.83

PFCF: −1.76

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-17.96M
-
-30.53M
69.95%
-51.47M
68.56%
-6.48M
87.42%
-3.31M
48.95%
1.73M
152.24%
-4.18M
342.21%
-12.34M
194.93%
-7.17M
41.87%
-22.11M
208.28%
depreciation and amortization
291K
-
9.83M
3,278.35%
6.32M
35.73%
2.14M
66.16%
1.38M
35.64%
1.44M
4.87%
-188K
-
deferred income tax
stock based compensation
9.97M
-
12.68M
27.13%
371K
97.07%
562K
51.48%
23K
95.91%
320K
1,291.30%
329K
2.81%
84K
74.47%
314K
273.81%
1.47M
368.79%
change in working capital
-271K
-
-2.38M
776.75%
-156K
93.43%
3.05M
2,056.41%
-1.23M
140.24%
25K
102.04%
-214K
956%
243K
213.55%
-450K
285.19%
66K
114.67%
accounts receivables
inventory
accounts payables
-158K
-
458K
389.87%
-344K
175.11%
-261K
24.13%
-67K
74.33%
74K
210.45%
-64K
186.49%
499K
879.69%
-186K
137.27%
66K
135.48%
other working capital
-113K
-
-2.83M
2,407.96%
188K
106.63%
3.31M
1,662.23%
-1.16M
135.04%
-49K
95.78%
-150K
206.12%
-256K
70.67%
-264K
3.13%
-66K
75%
other non cash items
2.70M
-
885K
67.27%
40.31M
4,455.03%
794K
98.03%
-137K
117.25%
-6.24M
4,457.66%
1.05M
116.83%
7.99M
660.13%
704K
91.19%
10.16M
1,343.18%
net cash provided by operating activities
-5.27M
-
-9.52M
80.57%
-4.62M
51.45%
70K
101.52%
-3.27M
4,774.29%
-2.73M
16.60%
-3.02M
10.55%
-4.02M
33.28%
-6.60M
64.21%
-10.60M
60.49%
investments in property plant and equipment
-2M
-
-1.00M
49.80%
-2K
99.80%
-4K
100%
675K
16,975%
-36K
105.33%
-360K
900%
-1.47M
308.06%
acquisitions net
2.66M
-
-675K
-
360K
-
460K
27.78%
purchases of investments
-7.99M
-
-18.04M
125.61%
-12.27M
31.94%
-15.20M
23.86%
-8.66M
43.03%
-98.83M
1,041.06%
-93.43M
5.46%
-41.81M
55.25%
sales maturities of investments
8.12M
-
15.06M
85.51%
14.21M
5.66%
15.06M
5.97%
10.28M
31.76%
74.87M
628.55%
103.04M
37.62%
28.66M
72.19%
other investing activites
4K
-
-675K
-
26K
103.85%
-360K
1,484.62%
-18.46M
-
-1.44M
92.19%
net cash used for investing activites
662K
-
-1M
251.06%
125K
112.50%
-2.97M
2,479.20%
1.26M
142.50%
-151K
111.95%
1.26M
931.79%
-24.96M
2,087.50%
-8.85M
64.54%
-14.60M
64.89%
debt repayment
common stock issued
310K
-
3.87M
1,149.68%
4.77M
23.05%
2.14M
55.11%
2.10M
2.10%
2.70M
28.88%
1.94M
28.11%
24.40M
1,157.29%
78.22M
220.52%
17.89M
77.13%
common stock repurchased
-14.06M
-
-935K
93.35%
-4K
99.57%
-24K
500%
dividends paid
other financing activites
2.92M
-
18.39M
528.62%
760K
-
-106K
-
7.20M
6,896.23%
84K
98.83%
-25.08M
29,961.90%
net cash used provided by financing activities
3.23M
-
8.20M
153.35%
3.83M
53.25%
2.90M
24.43%
2.07M
28.49%
2.70M
30.37%
1.83M
32.04%
31.61M
1,622.51%
78.30M
147.73%
-7.19M
109.19%
effect of forex changes on cash
net change in cash
-1.37M
-
-2.32M
68.97%
-663K
71.42%
-8K
98.79%
63K
887.50%
-180K
385.71%
74K
141.11%
2.62M
3,445.95%
62.85M
2,295.08%
-32.39M
151.53%
cash at beginning of period
4.50M
-
3.13M
30.52%
805K
74.24%
142K
82.36%
134K
5.63%
197K
47.01%
17K
91.37%
91K
435.29%
2.71M
2,883.52%
65.56M
2,314.81%
cash at end of period
3.13M
-
805K
74.24%
142K
82.36%
134K
5.63%
197K
47.01%
17K
91.37%
91K
435.29%
2.71M
2,883.52%
65.56M
2,314.81%
33.17M
49.40%
operating cash flow
-5.27M
-
-9.52M
80.57%
-4.62M
51.45%
70K
101.52%
-3.27M
4,774.29%
-2.73M
16.60%
-3.02M
10.55%
-4.02M
33.28%
-6.60M
64.21%
-10.60M
60.49%
capital expenditure
-2M
-
-1.00M
49.80%
-2K
99.80%
-4K
100%
675K
16,975%
-36K
105.33%
-360K
900%
-1.47M
308.06%
free cash flow
-7.27M
-
-10.52M
44.70%
-4.62M
56.06%
66K
101.43%
-2.60M
4,034.85%
-2.77M
6.47%
-3.38M
22.13%
-5.49M
62.57%
-6.60M
20.27%
-10.60M
60.49%

All numbers in USD (except ratios and percentages)